ChartRow logo
ChartRow
Investing Charts
DXCM
DexCom Inc.Stock · HealthcareNasdaq-100 0.1% · S&P 500 0.0%
$71.54+$1.06 (+1.50%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

DXCM financial statements

The full income statement, balance sheet, and cash-flow statement for DexCom Inc. (DXCM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
4.66B
YoY+15.6%
4.03B
YoY+11.3%
3.62B
YoY+24.5%
2.91B
YoY+18.8%
2.45B
YoY+27.1%
2.80B
YoY+14.9%
2.44B
YoY+6.5%
2.29B
YoY+21.5%
1.88B
YoY+12.1%
1.68B
YoY+31.3%
1.89B
YoY+2.8%
1.84B
YoY+8.7%
1.69B
YoY+13.4%
1.49B
YoY+5.5%
1.41B
YoY+44.3%
Operating income
912M
YoY+52.0%
600M
YoY+0.4%
598M
YoY+52.8%
391M
YoY+47.2%
266M
YoY-11.3%
Interest expense
18.3M
YoY-3.7%
19.0M
YoY-6.4%
20.3M
YoY+9.1%
18.6M
YoY-1.1%
18.8M
YoY+6.2%
Other non-operating income
177M
YoY+62.0%
109M
YoY-3.3%
113M
YoY+28275.0%
-400K
YoY+95.6%
-9.00M
YoY-155.9%
Pre-tax income
1.09B
YoY+53.5%
709M
YoY-0.2%
710M
YoY+81.8%
391M
YoY+52.2%
257M
YoY-13.8%
Income tax
252M
YoY+89.8%
133M
YoY-21.4%
169M
YoY+240.5%
49.6M
YoY+24.3%
39.9M
YoY+115.8%
Net income
836M
YoY+45.1%
576M
YoY+6.4%
542M
YoY+58.7%
341M
YoY+57.3%
217M
YoY-60.5%
$2.09
YoY+47.2%
$1.42
YoY+9.2%
$1.30
YoY+58.5%
$0.82
YoY+54.7%
$0.53
YoY-60.2%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
4.03B
YoY-6.2%
4.30B
YoY-2.8%
4.43B
YoY+20.6%
3.67B
YoY-0.4%
3.68B
YoY+7.6%
6.34B
YoY-2.2%
6.48B
YoY+3.5%
6.26B
YoY+16.2%
5.39B
YoY+9.3%
4.93B
YoY+15.0%
2.14B
YoY-26.9%
2.93B
YoY+88.4%
1.56B
YoY-15.4%
1.84B
YoY+155.2%
721M
YoY+17.4%
3.59B
YoY-18.0%
4.38B
YoY+4.4%
4.20B
YoY+28.7%
3.26B
YoY+12.8%
2.89B
YoY+17.3%
2.75B
YoY+30.6%
2.10B
YoY+1.6%
2.07B
YoY-3.0%
2.13B
YoY+4.4%
2.04B
YoY+31.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.44B
YoY+45.6%
990M
YoY+32.2%
749M
YoY+11.8%
670M
YoY+51.3%
443M
YoY-7.0%
536M
YoY+358.3%
-208M
YoY+59.1%
-507M
YoY+2.7%
-522M
YoY-141.3%
-216M
YoY+78.8%
-1.69B
YoY-129.5%
-735M
YoY-130.6%
-319M
YoY+42.3%
-553M
YoY-5412.5%
10.4M
YoY-98.9%
FX effect on cash
21.5M
YoY+390.5%
-7.40M
YoY-593.3%
1.50M
YoY+125.9%
-5.80M
YoY-314.3%
-1.40M
YoY-166.7%
Net change in cash
312M
YoY+683.4%
39.8M
YoY+152.5%
-75.8M
YoY+81.5%
-410M
YoY-274.3%
235M
YoY-36.7%
Interest paid
11.4M
YoY+0.0%
11.4M
YoY-8.1%
12.4M
YoY+1.6%
12.2M
YoY+5.2%
11.6M
YoY+9.4%
Income taxes paid
94.4M
YoY-52.3%
198M
YoY-6.7%
212M
YoY+85.9%
114M
YoY+579.8%
16.8M
YoY+366.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
25.5B
YoY-15.9%
30.4B
YoY-36.6%
47.9B
YoY+9.6%
43.7B
YoY-16.1%
52.1B
YoY+46.6%
P/E
30.5×
YoY-42.1%
52.7×
YoY-58.5%
127.2×
YoY-29.0%
179.2×
YoY-25.4%
240.3×
YoY+271.5%
P/S
5.5×
YoY-27.3%
7.5×
YoY-46.5%
14.1×
YoY-10.0%
15.7×
YoY-26.4%
21.3×
YoY+15.3%
P/B
9.3×
YoY-35.6%
14.5×
YoY-31.6%
21.1×
YoY-11.8%
24.0×
YoY-6.1%
25.5×
YoY+11.4%
P/FCF
23.7×
YoY-50.8%
48.2×
YoY-49.8%
95.9×
YoY-42.7%
167.4×
YoY-82.9%
977.8×
YoY+660.6%
3.3%
YoY+72.7%
1.9%
YoY+141.1%
0.79%
YoY+40.9%
0.56%
YoY+34.1%
0.42%
YoY-73.1%
4.2%
YoY+103.2%
2.1%
YoY+99.1%
1.0%
YoY+74.5%
0.60%
YoY+484.2%
0.10%
YoY-86.9%
Source filing10-K10-K10-K10-K10-K

About this data

Source: DXCM's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all DXCM filings on SEC EDGAR → Not investment advice.